Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004404 · ClinicalTrials.gov registry record · NA
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00004404 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT00004404, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
Interventions
- DRUG hydroxyurea
- DRUG clotrimazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1997-04 |
| Est. Completion | 2002-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004404
The ClinicalTrials.gov registry entry for NCT00004404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hydroxyurea is the first listed.
NCT00004404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004404 about?
NCT00004404 is a clinical study titled "Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes". OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
What is the current status of trial NCT00004404?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1997-04. Estimated completion is 2002-09.
What interventions are being tested in trial NCT00004404?
The interventions under investigation include: hydroxyurea (DRUG), clotrimazole (DRUG).
Who is sponsoring clinical trial NCT00004404?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.